Diversify Advisory Services LLC Invests $5.82 Million in Stryker Corporation $SYK

Diversify Advisory Services LLC acquired a new stake in shares of Stryker Corporation (NYSE:SYK) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 17,275 shares of the medical technology company’s stock, valued at approximately $5,817,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Gables Capital Management Inc. purchased a new stake in shares of Stryker during the second quarter valued at approximately $25,000. Strategic Wealth Advisors LLC raised its holdings in Stryker by 50.4% in the 2nd quarter. Strategic Wealth Advisors LLC now owns 197 shares of the medical technology company’s stock worth $62,000 after acquiring an additional 66 shares during the last quarter. First National Bank of Omaha lifted its position in Stryker by 61.4% in the 2nd quarter. First National Bank of Omaha now owns 8,129 shares of the medical technology company’s stock valued at $2,639,000 after acquiring an additional 3,092 shares in the last quarter. Navigoe LLC bought a new position in Stryker in the 2nd quarter valued at approximately $34,000. Finally, Citizens Financial Group Inc. RI boosted its stake in Stryker by 3.8% during the 2nd quarter. Citizens Financial Group Inc. RI now owns 67,075 shares of the medical technology company’s stock valued at $21,118,000 after purchasing an additional 2,464 shares during the last quarter. 77.09% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Stryker

In other Stryker news, Director Ronda E. Stryker sold 310,000 shares of the business’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the completion of the sale, the director directly owned 1,924,880 shares in the company, valued at $601,005,282.40. The trade was a 13.87% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Debra King sold 826 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total transaction of $277,783.80. Following the sale, the insider directly owned 6,210 shares of the company’s stock, valued at $2,088,423. The trade was a 11.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 315,370 shares of company stock worth $98,463,501 in the last three months. 4.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on SYK. Citigroup restated a “buy” rating on shares of Stryker in a research note on Thursday, August 13th. Wolfe Research cut Stryker from an “outperform” rating to a “peer perform” rating in a research report on Thursday, August 13th. JPMorgan Chase & Co. reduced their price objective on Stryker from $400.00 to $350.00 and set an “overweight” rating for the company in a report on Friday, July 31st. Wells Fargo & Company decreased their target price on Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Finally, Canaccord Genuity Group lowered their target price on shares of Stryker from $435.00 to $400.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $386.28.

Stryker Price Performance

Shares of SYK opened at $331.96 on Wednesday. The firm has a fifty day simple moving average of $325.56 and a two-hundred day simple moving average of $333.05. The firm has a market cap of $127.33 billion, a PE ratio of 34.40, a P/E/G ratio of 2.16 and a beta of 0.76. The company has a current ratio of 2.16, a quick ratio of 1.33 and a debt-to-equity ratio of 0.59. Stryker Corporation has a 1-year low of $281.00 and a 1-year high of $396.86.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The firm had revenue of $6.59 billion for the quarter, compared to the consensus estimate of $6.58 billion. During the same period last year, the business posted $3.13 EPS. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, equities analysts anticipate that Stryker Corporation will post 15.02 EPS for the current year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s dividend payout ratio (DPR) is presently 36.48%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.